Vitamin D may help prevent those at risk for diabetes from developing the disease, giving doctors and patients a potential tool against the condition, researchers said.
Scientists have uncovered gene mutations that slash the risk of Type 2 diabetes regardless of age and weight, offering drugmakers a novel target to combat one of the major health threats confronting the modern world.
Eli Lilly & Co. and Boehringer Ingelheim GmbH won U.S. approval of a new drug to improve blood glucose control in people with Type 2 diabetes.
Type 2 diabetes is harder to treat in children ages 10 to 17 than it is in adults, according to one of the first large studies of the disease in younger people.
Poxel SA has raised 13 million euros ($17.1 million) in venture backing, which it plans to use to start a mid-stage clinical trial for its experimental Type 2 diabetes drug.